SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-16-132418
Filing Date
2016-07-13
Accepted
2016-07-13 16:46:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D a16-14899_2sc13d.htm SC 13D 50215
  Complete submission text file 0001104659-16-132418.txt   51650
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85963 | Film No.: 161765979
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Filed by) CIK: 0001679076 (see all company filings)

Type: SC 13D